Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma-Reference-Cited by-同舟云学术

Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma

Published:2010 Issue:10 Volume:57 Page:873-880
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Sato Shuichi¹,Muraishi Kazuhisa¹,Tani Junichi¹,Sasaki Yuko¹,Tokubuchi Ichiro¹,Tajiri Yuji¹,Yamada Kentaro¹,Suekane Shigetaka²,Miyajima Jiro²,Matsuoka Kei²,Hiromatsu Yuji¹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan

2. Department of Urology, Kurume University School of Medicine, Fukuoka, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/57/10/57_K10E-130/_pdf

Reference15 articles.

1. 1. Torino F, Corsello SM, Longo R, Barnabei A, Gasparini G. (2009) Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. Nat Rev Clin Oncol 6: 219-228.

2. 2. Ivy SP, Wick JY, Kaufman BM. (2009) An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 6: 569-579.

3. 3. Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM. (2007) Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 99: 81-83.

4. 4. Wong E, Rosen LS, Mulay M, Vanvugt A, Dinolfo M, Tomoda C, Sugawara M, Hershman JM. (2007) Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 17: 351-355.

5. 5. Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, Morgan JA, Dychter SS, Larsen PR, Demetri GD, Alexander EK. (2006) Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 145: 660-664.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-related adverse events of cancer immunotherapies targeting kinases;Pharmacology & Therapeutics;2022-09

2. Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer;Clinical Cancer Research;2022-04-01

3. Dysthyroïdies;Échographie Thyroïdienne et Parathyroïdienne;2021

4. Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs);Trends in Endocrinology & Metabolism;2020-03

5. Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors;Drug Metabolism Reviews;2019-10-02